Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed in the Phase I/II clinical trial of its ...
The ASX lifted as Wall Street sniffed a rate cut, while Qube ripped higher on a Macquarie takeover bid. ... Read More The ...
Sino Biopharmaceutical ( ($HK:1177) ) has shared an update. Sino Biopharmaceutical Limited announced that its innovative drug, LM-350 ‘CDH17 ADC’, ...
The mood was positive as investors digested a fresh wave of global signals and a chunky dose of local corporate drama. Over on Wall Street last Friday, US stocks managed to rally strongly. The S&P 500 ...
Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant NSCLC Received FDA IND clearance for ARR-217, a CDH-17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback